Navigation Links
Stem Cell Therapy Holds Promise for Kidney Disease

By Denise Mann
HealthDay Reporter

THURSDAY, Aug. 4 (HealthDay News) -- Researchers may be one step closer to harnessing the power of stem cells to help treat, and potentially cure, kidney disease.

Two new studies, both published in a recent issue of the Journal of the American Society of Nephrology, demonstrate that kidney cells can be reprogrammed to morph into other types of kidney cells needed to repair damage.

In one report, scientists out of Monash University in Australia extracted kidney cells and reprogrammed them so they could behave like other kidney cells. In a second related study, researchers from the Chinese Academy of Sciences in Guangzhou, China, collected kidney cells from urine and were also able to reprogram them.

The next step is to see if the cell lines -- called induced pluripotent stem cells (iPSC) -- can be expanded, and then injected back into people with kidney disease to develop functional tissue and/or organs. While this may be years off and there are many steps left to take, the technology has the potential to cure certain hereditary forms of kidney disease and acute kidney injury, and could eliminate the need for dialysis and/or kidney transplants in some patients with end-stage kidney disease.

Dr. Ivonne Schulman, an assistant professor of clinical medicine and nephrologist at the University of Miami's Interdisciplinary Stem Cell Institute in Florida, said that this is the first time that researchers have shown that kidney cells could be reprogrammed and made to behave like embryonic stem cells, meaning they have the potential to differentiate into other types of kidney cells.

"Two papers back-to-back show that two different kidney cell types are able to be reprogrammed," she said. "This is very significant."

The ultimate goal would be to inject these cells back into patients and try to regenerate kidney tissue, Schulman explained. "It could theoretically help all types of kidney disease," she said. "It just depends on the ability of these cells to differentiate back into the cell types needed for that disease."

In one of the studies, researchers were able to collect the kidney cells from urine, which means that they could be collected at anytime, eliminating the need for cell banks. "This makes it very simple," Schulman added.

Dr. Jeffrey I. Silberzweig, co-medical director of the Rogosin Institute Manhattan Dialysis Center in New York City, said that the benefits could be exponential. "The idea that you can have the ability to do stem cell transplants during the early stage of kidney disease and regenerate the damaged part of the kidney would be a tremendous benefit for patients and the country as a whole," he said.

The current treatment for end-stage kidney disease includes dialysis and/or kidney transplantation. Dialysis, which outsources kidney function, is uncomfortable, time-consuming and costly, he noted. Plus, "the supply of kidneys available for transplantation is way behind the number of people who need them," Silberzweig said. Intervening earlier with stem cell therapy could prevent things from ever getting that far.

"If it reaches a point where this technology becomes practical, patients would fall over each other getting in line to do it," Silberzweig said.

"This is a critical and important first step," said Dr. Samuel Saltzberg, a transplant nephrologist at Rush University Medical Center in Chicago. "We have quite a way to go to get to a point where we can impact kidney disease -- especially in diseases when the whole organ needs to be repaired."

In an editorial accompanying the new studies, Dr. Ian Rogers of Mount Sinai Hospital in Toronto wrote that kidney disease may just be the tip of the iceberg. "The advantage of these cells for the diagnosis and treatment of kidney disease is great -- but the ease of collection and the high frequency of reprogramming also means there may be benefits to urine cells for iPSC production beyond kidney disease."

More information

Learn more about kidney disease at the National Kidney Foundation.

SOURCES: Jeffrey I. Silberzweig, M.D., co-medical director, Rogosin Institute Manhattan Dialysis Center, New York City; Samuel Saltzberg, M.D., transplant nephrologist, Rush University Medical Center, Chicago; Ivonne Schulman, M.D., assistant professor, clinical medicine, and nephrologist, University of Miami's Interdisciplinary Stem Cell Institute, Miami; July 2011, Journal of the American Society of Nephrology

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Nicotine replacement therapy is over-promoted since most ex-smokers quit unassisted
2. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
3. Longview Therapy Center, PLLC, Unveils Its Definition Of Hope
4. Short-term radiation therapy successful on breast cancer
5. ASCROs Response to NY Times Articles on Radiation Therapy Incidents
6. Children With Cerebral Palsy Benefitting From New Physical Therapy Regimen
7. DavisPTnetwork Partners with the New York Physical Therapy Association to Provide Online Continuing Education
8. Behavioral therapy improves sleep and lives of patients with pain
9. WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
10. Promising therapy for relapsing multibple sclerosis
11. Split-course palliative radiotherapy confirmed as effective treatment for advanced NSCLC
Post Your Comments:
Related Image:
Stem Cell Therapy Holds Promise for Kidney Disease
(Date:11/27/2015)... ... November 27, 2015 , ... ... well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for ... of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ ...
(Date:11/27/2015)... ... , ... CBD College is proud to announce that on November ... to its Diagnostic Medical Sonography program. CBD College is honored to join this very ... and universities in the state of California make the cut. CBD College is officially ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... contact center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term ... fully supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of ...
(Date:11/26/2015)... Ashburn, VA (PRWEB) , ... November 26, 2015 ... ... Planners, an American Express Travel Representative. As a franchise owner, Somu now offers ... range of cruise, destination wedding packages, private cruise sales, as well as, cabin ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, ... in the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted ... 8th through Wednesday, November 11th, 2015. The conference was held at the Hawaii ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... Nov. 25, 2015 AAIPharma Services Corp./Cambridge ... of at least $15.8  Million to expand its ... NC . The expansion will provide additional ... the growing demands of the pharmaceutical and biotechnology ... expansion will provide up to 40,000 square feet ...
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Henry Schein, ... and services to office-based dental, medical and animal health ... (GNYDM) Meeting the Henry Schein ConnectDental® Pavilion , ... broadest array of open solutions designed to help any ... Click here for a schedule of experts ...
Breaking Medicine Technology: